Aegerion Pharmaceuticals
Aegerion Pharmaceuticals engages in the development of therapeutics and pharmaceuticals to treat cardiovascular and metabolic diseases. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€82—123m (Dealroom.co estimates Jun 2006.)
Bridgewater Massachusetts (HQ)
Authorizing premium user...